Striatal dopamine type 2 receptor availability in anorexia nervosa

Psychiatry Research - Neuroimaging

Volumn 233, Issue 3, 2015, Pages 380-387

  Broft, Allegra ^a   Slifstein, Mark ^a   Osborne, Joseph ^b,c   Kothari, Paresh ^b   Morim, Simon ^b   Shingleton, Rebecca ^a,d   Kenney, Lindsay ^a   Vallabhajosula, Shankar ^b   Attia, Evelyn ^a   Martinez, Diana ^a   Timothy Walsh, B ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d BOSTON UNIVERSITY   (United States)

Author keywords

Dopamine D2 receptor; Eating disorders; Neuroimaging; Positron Emission Tomography; Striatum; 11C raclopride

Indexed keywords

DOPAMINE 2 RECEPTOR; RACLOPRIDE C 11; DOPAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; RACLOPRIDE;

ADULT; ANOREXIA NERVOSA; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; HOSPITAL PATIENT; HUMAN; LIMBIC SYSTEM; NEUROIMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR BINDING; REWARD; SAMPLE SIZE; UNDERWEIGHT; WEIGHT GAIN; ADOLESCENT; DIAGNOSTIC IMAGING; LONGITUDINAL STUDY; METABOLISM; MIDDLE AGED; NEOSTRIATUM; PROCEDURES; YOUNG ADULT;

ADOLESCENT; ADULT; ANOREXIA NERVOSA; CORPUS STRIATUM; DOPAMINE; DOPAMINE ANTAGONISTS; FEMALE; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; NEOSTRIATUM; POSITRON-EMISSION TOMOGRAPHY; RACLOPRIDE; RECEPTORS, DOPAMINE D2; REWARD; YOUNG ADULT;

EID: 84952636458     PISSN: 09254927     EISSN: 18727506     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2015.06.013     Document Type: Article

References (39)

1. Bailer U.F., Frank G.K., Price J.C., Meltzer C.C., Becker C., Mathis C.A., Wagner A., Barbarich-Marsteller N.C., Bloss C.S., Putnam K., Schork N.J., Gamst A., Kaye W.H. Interaction between serotonin transporter and dopamine D2/D3 receptor radioligand measures is associated with harm avoidant symptoms in anorexia and bulimia nervosa. Psychiatry Res. 2013, 211(2):160-168.
2. Beaulieu J.M., Gainetdinov R.R. The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol. Rev. 2011, 63(1):182-217.
3. Broft A., Shingleton R., Kaufman J., Liu F., Kumar D., Slifstein M., Abi-Dargham A., Schebendach J., Van Heertum R., Attia E., Martinez D., Walsh B.T. Striatal dopamine in bulimia nervosa: a PET imaging study. Int. J. Eat. Disord. 2012, 45(5):648-656.
4. Czoty P.W., Riddick N.V., Gage H.D., Sandridge M., Nader S.H., Garg S., Bounds M., Garg P.K., Nader M.A. Effect of menstrual cycle phase on dopamine D2 receptor availability in female cynomolgus monkeys. Neuropsychopharmacology 2009, 34(3):548-554.
5. de Weijer B.A., van de Giessen E., van Amelsvoort T.A., Boot E., Braak B., Janssen I.M., van de Laar A., Fliers E., Serlie M.J., Booij J. Lower striatal dopamine D2/3 receptor availability in obese compared with non-obese subjects. EJNMMI Res. 2011, 1(1):37.
6. Fairburn C. The Eating Disorder Examination 1993, Guilford, New York. 12th ed.
7. Faul F., E.E., Lang, A.G., Buchner, A., 2009. GPower 3.1.9.2.
8. First, M., Gibbon, M., Williams, J.B.W., 1995. Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition (SCIDP), Version 2. New York State Psychiatric Institute, Biometrics Research, New York.
9. Forbush K.T., South S.C., Krueger R.F., Iacono W.G., Clark L.A., Keel P.K., Legrand L.N., Watson D. Locating eating pathology within an empirical diagnostic taxonomy: evidence from a community-based sample. J. Abnorm. Psychol. 2010, 119(2):282-292.
10. Ford C.P. The role of D2-autoreceptors in regulating dopamine neuron activity and transmission. Neuroscience 2014, 282C:13-22.
11. Frank G.K., Bailer U.F., Henry S.E., Drevets W., Meltzer C.C., Price J.C., Mathis C.A., Wagner A., Hoge J., Ziolko S., Barbarich-Marsteller N., Weissfeld L., Kaye W.H. Increased dopamine D2/D3 receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [11c]raclopride. Biol. Psychiatry 2005, 58(11):908-912.
12. Frank G.K., Reynolds J.R., Shott M.E., Jappe L., Yang T.T., Tregellas J.R., O'Reilly R.C. Anorexia nervosa and obesity are associated with opposite brain reward response. Neuropsychopharmacology 2012, 37(9):2031-2046.
13. Hirvonen J., Karlsson H., Kajander J., Markkula J., Rasi-Hakala H., Nagren K., Salminen J.K., Hietala J. Striatal dopamine D2 receptors in medication-naive patients with major depressive disorder as assessed with [11c]raclopride PET. Psychopharmacology 2008, 197(4):581-590.
14. Innis R.B., Cunningham V.J., Delforge J., Fujita M., Gjedde A., Gunn R.N., Holden J., Houle S., Huang S.C., Ichise M., Iida H., Ito H., Kimura Y., Koeppe R.A., Knudsen G.M., Knuuti J., Lammertsma A.A., Laruelle M., Logan J., Maguire R.P., Mintun M.A., Morris E.D., Parsey R., Price J.C., Slifstein M., Sossi V., Suhara T., Votaw J.R., Wong D.F., Carson R.E. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J. Cereb. Blood Flow Metab. 2007, 27(9):1533-1539.
15. Kaye W.H., Wierenga C.E., Bailer U.F., Simmons A.N., Wagner A., Bischoff-Grethe A. Does a shared neurobiology for foods and drugs of abuse contribute to extremes of food ingestion in anorexia and bulimia nervosa?. Biol. Psychiatry 2013, 73(9):836-842.
16. Kim J.H., Son Y.D., Kim H.K., Lee S.Y., Cho S.E., Kim Y.B., Cho Z.H. Effects of age on dopamine D2 receptor availability in striatal subdivisions: a high-resolution positron emission tomography study. Eur. Neuropsychopharmacol. 2011, 21(12):885-891.
17. Klanker M., Feenstra M., Denys D. Dopaminergic control of cognitive flexibility in humans and animals. Front. Neurosci. 2013, 7:201.
18. Kontis D., Theochari E. Dopamine in anorexia nervosa: a systematic review. Behav. Pharmacol. 2012, 23(5-6):496-515.
19. Lammertsma A.A., Hume S.P. Simplified reference tissue model for PET receptor studies. Neuroimage 1996, 4(3 Pt. 1):153-158.
20. Martinez D., Broft A., Foltin R.W., Slifstein M., Hwang D.R., Huang Y., Perez A., Frankle W.G., Cooper T., Kleber H.D., Fischman M.W., Laruelle M. Cocaine dependence and d2 receptor availability in the functional subdivisions of the striatum: relationship with cocaine-seeking behavior. Neuropsychopharmacology 2004, 29(6):1190-1202.
21. Martinez D., Slifstein M., Broft A., Mawlawi O., Hwang D.R., Huang Y., Cooper T., Kegeles L., Zarahn E., Abi-Dargham A., Haber S.N., Laruelle M. Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: amphetamine-induced dopamine release in the functional subdivisions of the striatum. J. Cereb. Blood Flow Metab. 2003, 23(3):285-300.
22. Mawlawi O., Martinez D., Slifstein M., Broft A., Chatterjee R., Hwang D.R., Huang Y., Simpson N., Ngo K., Van Heertum R., Laruelle M. Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum. J. Cereb. Blood Flow Metab. 2001, 21(9):1034-1057.
23. Nikolaus S., Antke C., Beu M., Muller H.W. Cortical GABA, striatal dopamine and midbrain serotonin as the key players in compulsive and anxiety disorders--results from in vivo imaging studies. Rev. Neurosci. 2010, 21(2):119-139.
24. Parsey R.V., Oquendo M.A., Zea-Ponce Y., Rodenhiser J., Kegeles L.S., Pratap M., Cooper T.B., Van Heertum R., Mann J.J., Laruelle M. Dopamine D(2) receptor availability and amphetamine-induced dopamine release in unipolar depression. Biol. Psychiatry 2001, 50(5):313-322.
25. Perani D., Garibotto V., Gorini A., Moresco R.M., Henin M., Panzacchi A., Matarrese M., Carpinelli A., Bellodi L., Fazio F. In vivo PET study of 5HT(2A) serotonin and D(2) dopamine dysfunction in drug-naive obsessive-compulsive disorder. Neuroimage 2008, 42(1):306-314.
26. Pothos E.N., Creese I., Hoebel B.G. Restricted eating with weight loss selectively decreases extracellular dopamine in the nucleus accumbens and alters dopamine response to amphetamine, morphine, and food intake. J. Neurosci. 1995, 15(10):6640-6650.
27. Schneier F.R., Abi-Dargham A., Martinez D., Slifstein M., Hwang D.R., Liebowitz M.R., Laruelle M. Dopamine transporters, D2 receptors, and dopamine release in generalized social anxiety disorder. Depress. Anxiety 2009, 26(5):411-418.
28. Schneier F.R., Liebowitz M.R., Abi-Dargham A., Zea-Ponce Y., Lin S.H., Laruelle M. Low dopamine D(2) receptor binding potential in social phobia. Am. J. Psychiatry 2000, 157(3):457-459.
29. Schneier F.R., Martinez D., Abi-Dargham A., Zea-Ponce Y., Simpson H.B., Liebowitz M.R., Laruelle M. Striatal dopamine D(2) receptor availability in OCD with and without comorbid social anxiety disorder: preliminary findings. Depress. Anxiety 2008, 25(1):1-7.
30. Slifstein M., Laruelle M. Models and methods for derivation of in vivo neuroreceptor parameters with PET and SPECT reversible radiotracers. Nucl. Med. Biol. 2001, 28(5):595-608.
31. Sokoloff P., Giros B., Martres M.P., Bouthenet M.L., Schwartz J.C. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 1990, 347(6289):146-151.
32. Tchanturia K., Lounes N., Holttum S. Cognitive remediation in anorexia nervosa and related conditions: a systematic review. Eur. Eat. Disord. Rev. 2014, 22(6):454-462.
33. Treasure J., Schmidt U. The cognitive-interpersonal maintenance model of anorexia nervosa revisited: a summary of the evidence for cognitive, socio-emotional and interpersonal predisposing and perpetuating factors. J. Eat. Disord. 2013, 1:13.
34. Trifilieff P., Martinez D. Imaging addiction: D2 receptors and dopamine signaling in the striatum as biomarkers for impulsivity. Neuropharmacology 2014, 76(Pt. B):498-509.
35. Volkow N.D., Fowler J.S., Wang G.J., Baler R., Telang F. Imaging dopamine's role in drug abuse and addiction. Neuropharmacology 2009, 56(Suppl. 1):3-8.
36. Volkow N.D., Wang G.J., Fowler J.S., Logan J., Gatley S.J., Gifford A., Hitzemann R., Ding Y.S., Pappas N. Prediction of reinforcing responses to psychostimulants in humans by brain dopamine D2 receptor levels. Am. J. Psychiatry 1999, 156(9):1440-1443.
37. Volkow N.D., Wang G.J., Fowler J.S., Thanos P.P., Logan J., Gatley S.J., Gifford A., Ding Y.S., Wong C., Pappas N. Brain DA D2 receptors predict reinforcing effects of stimulants in humans: replication study. Synapse 2002, 46(2):79-82.
38. Volkow N.D., Wang G.J., Telang F., Fowler J.S., Thanos P.K., Logan J., Alexoff D., Ding Y.S., Wong C., Ma Y., Pradhan K. Low dopamine striatal D2 receptors are associated with prefrontal metabolism in obese subjects: possible contributing factors. Neuroimage 2008, 42(4):1537-1543.
39. Wang G.J., Volkow N.D., Logan J., Pappas N.R., Wong C.T., Zhu W., Netusil N., Fowler J.S. Brain dopamine and obesity. Lancet 2001, 357(9253):354-357.